# Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia

> **NCT04897217** · PHASE3 · WITHDRAWN · sponsor: **Wake Forest University Health Sciences**

## Conditions studied

- Endometrial Hyperplasia

## Interventions

- **DRUG:** Megestrol Acetate
- **DRUG:** Levonorgestrel Drug Implant

## Key facts

- **NCT ID:** NCT04897217
- **Lead sponsor:** Wake Forest University Health Sciences
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2023-06-30
- **Primary completion:** 2024-10
- **Final completion:** 2026-11
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** PI decision
- **Last updated:** 2023-07-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04897217

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04897217, "Levonorgestrel-Releasing Intrauterine System (LNG-IUS) in the Management of Atypical Endometrial Hyperplasia". Retrieved via AI Analytics 2026-06-10 from https://api.ai-analytics.org/clinical/NCT04897217. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*